Belief BioMed Inc.
PrivateLast Round
Series B
Mar 1, 2022
Total Funding Raised
$250.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Belief BioMed Inc. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in March 2022.
Belief BioMed Inc. is a biotechnology company that develops, manufactures, and commercializes adeno-associated virus (AAV) based gene therapies for genetic and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Belief BioMed Inc. Comparables
Compare Belief BioMed Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASC Therapeutics | 80% | |
| Frontera Therapeutics | 79% | |
| Sangamo Therapeutics Inc | 77% |
For institutional investors. Book with your work email.
Belief BioMed Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2022 | ||||
| Series B | Dec 1, 2020 | ||||
| Series A | Feb 1, 2020 | ||||
| Angel | Nov 1, 2018 | ||||
| Angel | Jun 19, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Belief BioMed Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B |
| Northern Light Venture Capital | Angel, Series A |
| Cenova Capital | Series B |
| MPC | Series B |
| CDG Capital | Series B |
| Lilly Asia Ventures | Series B |
| Sherpa Healthcare Partners | Angel, Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 38% MoM.
- Mar 27, 2026
Signed agreement for hemophilia A gene therapy in Greater China.
For institutional investors. Book with your work email.
Belief BioMed Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Belief BioMed Inc.'s valuation, stock price, and market status.
Is Belief BioMed Inc. a public or private company?
Belief BioMed Inc. is a private company.
What is the current stock price of Belief BioMed Inc.?
Belief BioMed Inc. is a private company, so its shares have no public market price. Caplight tracks Belief BioMed Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Belief BioMed Inc. worth (valuation)?
Valuation information for Belief BioMed Inc. is not publicly available.
Can I buy Belief BioMed Inc. stock?
Belief BioMed Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Belief BioMed Inc.'s last funding round?
Belief BioMed Inc.'s most recent funding round was Series B on March 1, 2022.
Who are the main investors in Belief BioMed Inc.?
Key investors in Belief BioMed Inc. include Lilly Asia Ventures.
Will Belief BioMed Inc. IPO soon?
No public IPO plans have been announced for Belief BioMed Inc..
How can I track Belief BioMed Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Belief BioMed Inc.'s shares on secondary markets.